Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Impact of Botulinum Toxin A Versus Anticholinergic Therapy for the Treatment of Bothersome Urge Urinary Incontinence

NCT01166438 is registered in ClinicalTrials.gov with NICHD Pelvic Floor Disorders Network as lead sponsor.

NCT NCT01166438
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01166438 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Impact of Botulinum Toxin A Versus Anticholinergic Therapy for the Treatment of Bothersome Urge Urinary Incontinence
Lead sponsor
NICHD Pelvic Floor Disorders Network
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2010
Completion date
May 31, 2012
Enrollment
249 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder, urge urinary incontinence